Image

Structural and Functional Characterization of Rare Ocular Diseases

Structural and Functional Characterization of Rare Ocular Diseases

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Rare ocular diseases (ROD) are a heterogeneous group of ocular diseases that affect very few people and, generally, for which no tretament is available. An important subgroup of these diseases are inherited retinal degenerations. In this study we focus on understanding the natural history of different ROD that affect the posterior segment.

Eligibility

Inclusion Criteria:

  • Male or female 18 years or older with a diagnosis of a ROD affecting the posterior segment
  • Patients able to undergo all required ophthalmic exams
  • Patients able and willing to sign an informed consent

Exclusion Criteria:

  • Patients with other concomitant posterior segment disorders
  • Patients taking drugs known to affect the retina and/or optic nerve
  • Patients that underwent an intraocular surgery (aside from phacoemulsification with intraocular lens implantation), corneal or glaucoma surgery
  • Patients who have participated in the past 12 months or that are currently participating in clinical trials for an ocular disease

Study details
    Retinitis Pigmentosa
    Stargardt Disease 1
    Best Disease
    Pattern Dystrophy of Macula
    Choroideremia

NCT05258032

Barcelona Macula Foundation

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.